Valrubicin

Generic Valstar

Used for Bladder Cancer

Basics Dosage Interactions Images Prices Medicare

VALRUBICIN treats bladder cancer. It works by slowing down the growth of cancer cells.

What is Valstar?

Overview

Valrubicin is used as a solution that is run through a tube (instilled through a catheter) into the bladder to treat bladder cancer.

Valrubicin is to be administered only by or under the immediate supervision of your doctor.

Commonly Used Brand Name(s)

Valstar

Therapeutic Classifications

Antineoplastic Agent

Chemical Classifications

Anthracycline

Proper Use

Your doctor may ask you to empty your bladder completely before the solution is instilled into it (unless a tube is used to drain the bladder).

Follow your doctor's instructions carefully about how long to hold the solution in your bladder:

The solution should be held in your bladder for 2 hours. If you think you cannot hold it, tell your health care professional.

It is important that you drink extra fluids after each treatment with valrubicin so that you will pass more urine.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

For bladder instillation dosage form (solution):
- For bladder cancer:
  - Adults—800 milligrams (mg) (75 milliliters [mL]) instilled into the bladder once a week for six weeks.

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of valrubicin in children with use in other age groups.

Geriatric

Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. Although there is no specific information comparing the use of valrubicin in the elderly with use in other age groups, this medicine has been used mostly in patients older than 60 years of age and is not expected to cause different side effects or problems in older people than it does in younger adults.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Drug Interactions

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

Tasonermin

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

Hexaminolevulinate
Margetuximab
Pertuzumab
Trastuzumab

Other Interactions

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Precautions

Valrubicin commonly causes the urine to turn red for about 24 hours after it is given. This is normal and is no cause for concern. However, tell your doctor if you continue to pass red urine for longer than 24 hours.